相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M. Aapro et al.
ANNALS OF ONCOLOGY (2008)
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma
Claudio Scavelli et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Zoledronic acid and angiogenesis
Gianluigi Ferretti et al.
CLINICAL CANCER RESEARCH (2007)
Osteonecrosis of the jaw.: A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates.: Report of five cases and review of the literature
Luigi Cavanna et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy
Estee P. Wang et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients - May 2006
Richard Weitzman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis
Cinzia Ortega et al.
ACTA ONCOLOGICA (2007)
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients
Kostas Zervas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws
S. Chiandussi et al.
DENTOMAXILLOFACIAL RADIOLOGY (2006)
Systematic review: Bisphosphonates and osteonecrosis of the jaws
Sook-Bin Woo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Jaw complications in breast and prostate cancer patients treated with zoledronic acid
C Ortega et al.
ACTA ONCOLOGICA (2006)
Mechanisms of Disease: preclinical reports of antineoplastic synergistic action of bisphosphonates
Daniele Santini et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
A Bamias et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment
RE Marx et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)
The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib
T Mashiba et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2005)
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
SL Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
RE Marx
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
F Saad et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
J Wood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
分享论文
